8-K: Perrigo Reports Solid Q3 2024 Results with Margin Expansion and Infant Formula Recovery

Perrigo's third quarter results show significant operating income growth and margin expansion, driven by the infant formula business recovery and cost-saving initiatives, despite a slight decrease in net sales.

Summary

• Perrigo reported a 3.2% decrease in net sales to $1.1 billion for the third quarter of 2024 compared to the same period last year.
• Organic net sales declined by 2.4%, primarily due to lost distribution of lower margin products in the U.S. Store Brand.
• However, the company saw a 160 basis point expansion in adjusted gross margin to 41.0%, driven by infant formula recovery and supply chain improvements.
• Adjusted operating income increased by 21.3% to $182 million, with adjusted operating margin expanding 340 basis points to 16.8%.
• The infant formula business showed a strong recovery, with net sales growing 3% year-over-year and 58% sequentially from the second quarter of 2024.
• Adjusted diluted earnings per share (EPS) increased by 26.6% to $0.81.
• The company reaffirmed its fiscal year 2024 adjusted EPS outlook of $2.50 to $2.65.
• Project Energize, a cost-saving program, is expected to deliver $140 million to $170 million in annualized pre-tax savings by 2026.
• Year-to-date, Project Energize has achieved gross savings of approximately $95 million while reinvesting $16 million into building critical capabilities.
• The company used proceeds from a senior notes offering to prepay $390 million of its Term Loan B and fully redeem $700 million of its 4.375% Senior Notes due in 2026, lowering its average interest rate.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong improvements in profitability and a recovering infant formula business. However, the decrease in net sales and the lower end of the sales outlook temper the overall sentiment.

Positives

• The company achieved significant margin expansion in both gross and operating margins.
• The infant formula business is showing strong signs of recovery with substantial sales growth.
• Adjusted earnings per share saw a significant increase.
• Project Energize is on track to deliver substantial cost savings.
• The company has taken steps to strengthen its balance sheet by refinancing debt and lowering its average interest rate.
• Perrigo is making progress on its 'One Perrigo' vision by stabilizing core businesses and investing in capabilities.

Negatives

• Net sales decreased by 3.2% in the third quarter of 2024.
• Organic net sales declined by 2.4% due to lost distribution of lower margin products.
• Reported diluted loss per share was $(0.13), compared to reported diluted earnings per share of $0.11 in the prior year quarter.
• The company expects its fiscal 2024 organic net sales and reported net sales outlooks towards the lower end of its previously stated ranges.

Risks

• The company faces challenges from lost distribution of lower margin products in the U.S. Store Brand.
• There are potential risks associated with the integration of acquisitions and the execution of cost-reduction efforts.
• The company is exposed to fluctuations in currency exchange rates and interest rates.
• There are risks related to supply chain impacts, economic conditions, and potential conflicts in regions where the company operates.
• The company's forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially.

Future Outlook

The company expects its fiscal 2024 organic net sales and total net sales outlook to be towards the lower end of their previously stated ranges. The company reaffirms its adjusted diluted EPS outlook of $2.50 to $2.65. They also expect gross and operating margin expansion, interest expense of approximately $180 million, a full year adjusted tax rate of 19% to 20%, and operating cash flow conversion of approximately 90% to 100%.

Management Comments

• President and CEO, Patrick Lockwood-Taylor, stated that the company made significant progress to advance its One Perrigo vision.
• Lockwood-Taylor noted that the company delivered strong third quarter earnings results, despite topline impacts from lost distribution.
• He highlighted the significant progress in the infant formula business recovery.
• Lockwood-Taylor mentioned that the Perrigo team remains focused on de-levering the balance sheet, free cash flow generation, and furthering the recovery of the infant formula business.

Industry Context

Perrigo's focus on consumer self-care aligns with the broader trend of consumers taking more responsibility for their health and wellness. The company's efforts to improve its supply chain and product mix are also in line with industry best practices. The recovery of the infant formula business is particularly relevant given recent supply chain disruptions in the sector.

Comparison to Industry Standards

• Perrigo's adjusted gross margin of 41.0% is comparable to other consumer healthcare companies, such as Haleon (which reported an adjusted operating margin of 23.2% in H1 2023) and Reckitt Benckiser (which reported an adjusted operating margin of 23.5% in H1 2023), although these companies have a higher operating margin.
• The 21.3% increase in adjusted operating income is a strong result, indicating effective cost management and operational improvements, which is better than some of its peers.
• The infant formula market is highly competitive, with companies like Abbott and Nestle being major players. Perrigo's 3% year-over-year growth and 58% sequential growth in infant formula sales indicate a successful recovery strategy, but it is still a smaller player in the market.
• Project Energize's expected savings of $140 million to $170 million by 2026 is a significant cost-cutting initiative, which is comparable to similar programs undertaken by other large consumer goods companies.

Stakeholder Impact

• Shareholders will benefit from the increased profitability and adjusted EPS.
• Employees may be impacted by the restructuring efforts under Project Energize.
• Customers will benefit from the improved supply chain and product availability, particularly in the infant formula category.
• Creditors will see a reduced risk profile due to the company's debt refinancing efforts.

Next Steps

• The company will continue to execute Project Energize to achieve cost savings and improve operational efficiency.
• Perrigo will focus on de-levering the balance sheet and generating free cash flow.
• The company will continue to work on the recovery of the infant formula business.
• Perrigo will focus on building a solid foundation for long-term sustainable growth.

Key Dates

Keywords

Perrigo, Consumer Self-Care, Infant Formula, Gross Margin, Operating Income, Adjusted EPS, Project Energize, Debt Refinancing, Organic Net Sales, Cost Savings